The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Improved survival with sodium-glucose cotransporter-2 inhibitors and immune checkpoint inhibitors in metastatic solid tumors.
 
Sara Young
No Relationships to Disclose
 
Sean Dougherty
No Relationships to Disclose
 
Hector Picon
No Relationships to Disclose
 
Qingyi He
No Relationships to Disclose
 
Asal Pilehvari
No Relationships to Disclose
 
Wen You
No Relationships to Disclose
 
Richard Hall
Consulting or Advisory Role - Bayer; EMD Serono; Regeneron; Takeda
Research Funding - Amgen (Inst); AstraZeneca/MedImmune (Inst); Daiichi Sankyo/Lilly (Inst); Genentech (Inst); Lilly (Inst); Merck Sharp & Dohme (Inst); Mirati Therapeutics (Inst); Regeneron (Inst)
 
Matthew Reilley
Consulting or Advisory Role - Pfizer; Seattle Genetics/Astellas
Research Funding - AstraZeneca (Inst); Cardiff Oncology (Inst); Macrogenics (Inst); Merck (Inst); Pfizer (Inst); Surface Oncology (Inst); Takeda (Inst); Xencor (Inst); ZielBio (Inst)